Oxaliplatin plus hydroxycamptothecine versus oxaliplatin plus 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer

被引：0
|
作者：
YAO Yang SUN Yuanjue ZHAO Hui GUO Yuewu LIN Feng CAI Xun TANG Xiaochun TANG Lina and ZHANG Wei Department of Oncology Shanghai Sixth Peoples Hospital of Shanghai Jiaotong University Shanghai China Department of Epidemiology Cancer Research Institute of Shanghai Jiaotong University Shanghai China [200233 ,200032 ]
机构：
来源：
Chinese Medical Journal | 2006年 / 21期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1829 / 1833
页数：5
相关论文
共 50 条
  • [21] Bevacizumab plus infusional 5-fluorouracil, leucovorin and irinotecan for advanced colorectal cancer that progressed after oxaliplatin and irinotecan chemotherapy: A pilot study
    Kwon, Hyuk-Chan
    Oh, Sung Yong
    Lee, Suee
    Kim, Sung-Hyun
    Kim, Hyo-Jin
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (46) : 6231 - 6235
  • [22] Bevacizumab plus infusional 5-fluorouracil,leucovorin and irinotecan for advanced colorectal cancer that progressed after oxaliplatin and irinotecan chemotherapy:A pilot study
    Hyuk-Chan Kwon
    Sung Yong Oh
    Suee Lee
    Sung-Hyun Kim
    Hyo-Jin Kim
    [J]. World Journal of Gastroenterology, 2007, (46) : 6231 - 6235
  • [23] Randomized multicenter phase III trial of oxaliplatin plus raltitrexed compared to oxaliplatin plus fluorouracil and leucovorin treatment in recurrent and metastatic colorectal cancer
    Wang, J.
    Li, J.
    Qin, S.
    Liu, T.
    Ye, Z.
    Zheng, L.
    Tao, M.
    Zhuang, Z.
    Zhang, Q.
    Xu, N.
    Zhang, Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [24] Efficacy of oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX4) versus doxorabicin in advanced HCC: the EACH study
    Thongprasert, S.
    Qin, S.
    Lim, H.
    Bhudhisawasdi, V.
    Yin, X.
    Gang, W.
    Kim, B.
    Jian, Z.
    Yang, T.
    Rau, K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [25] Capecitabine plus oxaliplatin compared with 5-fluorouracil plus oxaliplatin in metastatic colorectal cancer: Meta-analysis of randomized controlled trials
    Zhang, Chengyao
    Wang, Jiawu
    Gu, Haitao
    Zhu, Daihua
    Li, Yang
    Zhu, Peng
    Wang, Yaxu
    Wang, Jijian
    [J]. ONCOLOGY LETTERS, 2012, 3 (04) : 831 - 838
  • [26] Oxaliplatin, 5-Fluorouracil, and Leucovorin as Second-Line Treatment for Advanced Pancreatic Cancer
    Novarino, Anna
    Satolli, Maria Antonietta
    Chiappino, Isabella
    Giacobino, Alice
    Bellone, Graziella
    Rahimi, Farnaz
    Milanesi, Enrica
    Bertetto, Oscar
    Ciuffreda, Libero
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (01): : 44 - 48
  • [27] 5-fluorouracil, leucovorin and oxaliplatin plus bevacizumab in the first-line treatment of metastatic colorectal cancer: A single-institute study
    Bir, Arvinder
    Tan, Wei
    Wilding, Gregory E.
    Lombardo, Jeffery
    Fakih, Marwan G.
    [J]. ONCOLOGY, 2007, 72 (1-2) : 4 - 9
  • [28] A randomized phase II trial of hepatic arterial infusion of oxaliplatin plus raltitrexed versus oxaliplatin plus 5-fluorouracil for unresectable colorectal cancer liver metastases
    Feng, Ai-Wei
    Guo, Jian-Hai
    Gao, Song
    Kou, Fu-Xin
    Liu, Shao-Xing
    Liu, Peng
    Chen, Hui
    Wang, Xiao-Dong
    Xu, Hai-Feng
    Cao, Guang
    Zhu, Xu
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [29] Oxaliplatin plus high-dose leucovorin and 5-fluorouracil in pretreated advanced breast cancer: a phase II study
    Pectasides, D
    Pectasides, A
    Farmakis, D
    Bountouroglou, N
    Nikolaou, M
    Koumpou, M
    Mylonakis, N
    Kosmas, C
    [J]. ANNALS OF ONCOLOGY, 2003, 14 (04) : 537 - 542
  • [30] Systemic treatment options in advanced colorectal cancer: Perspectives on combination 5-fluorouracil plus leucovorin
    Grem, JL
    [J]. SEMINARS IN ONCOLOGY, 1997, 24 (05) : 8 - 18
12345